Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Liabilities and Shareholders Equity: 2018

Historic Liabilities and Shareholders Equity for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2018 value amounting to $18.3 million.

  • DiaMedica Therapeutics' Liabilities and Shareholders Equity was N/A to $11.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was $57.7 million, marking a year-over-year change of. This contributed to the annual value of $18.3 million for FY2018, which is N/A change from last year.
  • DiaMedica Therapeutics' Liabilities and Shareholders Equity amounted to $18.3 million in FY2018.
  • Over the past 5 years, DiaMedica Therapeutics' Liabilities and Shareholders Equity peaked at $18.3 million during FY2018, and registered a low of $18.3 million during FY2018.
  • Over the past 1 years, DiaMedica Therapeutics' median Liabilities and Shareholders Equity value was $18.3 million (recorded in 2018), while the average stood at $18.3 million.